The Pentagon has released new guidelines for mandatory testosterone testing for male military personnel aged 30 and older. This action comes two weeks after the release and subsequent retraction of a previous policy. The updated guidelines currently do not include female personnel, and medical experts have raised questions about the necessity and effectiveness of such a program.
Details of the Testosterone Testing Program
Defense Secretary, Pete Hegseth, announced in July that a comprehensive screening program for military personnel to identify "testosterone deficiency" is being launched to help them perform at their best. The new clinical guidelines released last Thursday outline how this program will operate.
Read more: Massachusetts Officials Suggested Support for Challenged Parents
The Pentagon's effort to test personnel for low testosterone coincides with a growing public interest in this hormone, largely promoted by influencers and podcasts related to men's health. These influencers advocate treatments that help increase energy, build muscle, and feel younger.
However, many medical experts believe that these broad benefits are not supported by scientific evidence. Hegseth's remarks about the hormone have been a mix of documented scientific facts and broader, less substantiated claims.
Changes from Previous Policies
The Pentagon's previous guidelines included separate screening for female military personnel. Although this guideline did not mandate routine hormonal testing, it stated that women over 35 should be questioned about symptoms of hormonal disorders and referred for further evaluation if necessary. Guidelines for off-label testosterone prescriptions for women had also been provided.
The newly released guidelines specify that mandatory testing for "testosterone deficiency in male military personnel" will be conducted. The guidelines note that "clinical guidelines for women are under review and will be published upon approval." The Pentagon has not clarified whether female military personnel will be eligible for evaluation for estrogen-based treatments.
Testosterone levels naturally decline with age in men, affecting mood, sexual function, bone density, and other physical metrics. However, health experts have long debated how to accurately diagnose these issues and whether hormone replacement therapy is appropriate.
In the past decade, federal research has shown that increasing testosterone levels can help improve erectile dysfunction, low libido, and other medical concerns in men. Pentagon spokesperson Sean Parnell stated on Thursday that "by identifying and proactively treating suboptimal hormone levels," the Department of Defense aims to "invest in the health of its warriors, enhance their performance, and maximize force readiness."
Challenges and Considerations in Implementation
Major medical organizations generally recommend against routine and automatic testosterone level testing. Instead, standard clinical guidelines suggest testing for men who report specific symptoms — such as low libido and depressed mood — and obtaining two blood tests that confirm reduced hormone levels.
The Pentagon's policy diverges from this established approach, mandating testosterone testing for any male service member aged 30 and older, while also allowing younger personnel to request testing. In other aspects, the new protocol largely aligns with accepted medical standards and acknowledges the limited benefits of hormone replacement therapy.
For example, the document states: "There is no evidence to support its use for improving energy, vitality, physical performance, or cognition." Instead, it emphasizes "proven benefits" for sexual function and specific physical metrics, including bone density. This policy does not mandate replacement therapy if a service member qualifies, and the guidelines reference the long-standing side effects of hormonal treatment, including the potential reduction in sperm count.
Ultimately, practical considerations regarding steroids and the challenges associated with storing and using testosterone in military operational environments add to the difficulties in implementing this policy. The new guidelines specify that injectable testosterone "requires storage at controlled temperatures and auditing of controlled substances" and that service members receiving treatment must ensure they maintain adequate supplies, despite federal legal restrictions on prescribing controlled substances such as testosterone.
Read more: Death of an Unvaccinated Woman Due to Measles Complications in Pennsylvania · New York Yankees Confirmed Presence of Legionella Bacteria in Cooling Tower
Source: independent.co.uk
